MedTrace Logo

Efficacy Study of Granulocyte-macrophage Colony Stimulating Factor (GM-CSF) for Use in Human IVF

NCT00565747 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 1332

Last updated 2015-05-15

Study results available
· View outcomes & findings →

Summary

This study is to assess whether addition of 2 ng/ml GM-CSF into a specific culture medium will increase the chance of a pregnancy after in vitro fertilisation.

Conditions

Interventions

DEVICE

Test culture

A standard culture medium with added GM-CSF (ready-to-use)

DEVICE

Control culture

The same standard culture medium, but without any additions (ready-to-use)

Sponsors & Collaborators

  • Origio A/S

    lead INDUSTRY

Principal Investigators

  • Søren Ziebe, M.Sc. · Rigshospitalet, Fertilitetsklinikken afd. 4071

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
39 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-11-30
Primary Completion
2010-11-30
Completion
2011-09-30

Countries

  • Denmark
  • Sweden

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00565747 on ClinicalTrials.gov